REFERENCE
Jansen JP, Shavit O, Bergman G, Sen SS.Cost-effectiveness of Fosavance(Rm) in the treatment of osteoporosis in the Netherlands. Osteoporosis International 17 (Suppl. 2): 135, 2006
Rights and permissions
About this article
Cite this article
The combined osteoporosis treatment alendronic acid/colecalciferol [Fosavance] is cost saving and more effective than ibandronic acid in postmenopausal women in The Netherlands,. Pharmacoecon. Outcomes News 508, 8 (2006). https://doi.org/10.2165/00151234-200605080-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605080-00023